Dengue outbreaks occur in countries throughout the world on an all too frequent basis. One of the latest countries to experience an outbreak of the disease is the Philippines.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.